Cure SMA Offers Free Virtual Therapy Sessions

To help with stress or anxiety brought on by the COVID-19 pandemic or other issues, adult patients with spinal muscular atrophy (SMA) in the U.S. are being offered up to three half-hour live video sessions with a licensed therapist.

The Adults with SMA Virtual Therapy Program is free and presented by Cure SMA through the online therapy company Talkspace, a secure therapy platform that has licensed therapists in every state who can assist people with issues they are experiencing.

“It has never been more important to take care of our mental health as we continue to navigate through uncertain times,” according to the Cure SMA announcement. “Whether you are in the midst of a critical problem, are experiencing general distress, or just need someone to talk to, therapy is a valuable investment.”

Registrants must be at least 18 and live in the U.S. They should complete this request form, which is good for one session voucher. After completing the first session, patients have the option of submitting the form again to receive two more therapy vouchers for a maximum of three sessions.

Cure SMA will review each registration to confirm eligibility, and, once approved, registrants will get a confirmation email from Talkspace. After a brief assessment to determine which therapists may be the best fit, patients will be able decide who they would like to work with based on the recommendations.

Talkspace is an online service that primarily allows people to chat with a licensed therapist via text, audio, picture, or video messages in a private chat room.

For more information on wellness and mental health resources, CureSMA is offering a new Care Series booklet, “Caring for Your Emotional and Mental Health.” The resource outlines mental and emotional considerations for SMA patients and caregivers, as well as coping strategies.

Write to [email protected] with any questions or for more information. The program is sponsored by Genentech and the Dhont Family Foundation.

Cure SMA provides support to patients and families affected by SMA and funds and directs research research in treatment and care. The progressive genetic disorder affects 10,000 to 25,000 people in the U.S.